Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion type Assertion NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_head.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion wasGeneratedBy ECO_0000203 NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_provenance.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion wasDerivedFrom befree-2016 NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_provenance.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion SIO_000772 23754492 NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_provenance.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion evidence source_evidence_literature NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_provenance.
- NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_assertion description "[Increasing the expression of cyclin-cyclin-dependent kinase inhibitors (cyclin-CDK) using small molecule inhibitors is a therapeutic strategy used to suppress cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1084815.RApHrf2ugAYawZbJDwSiRmbwG5wSDxpQG87t_Vu5sRcak130_provenance.